HopeStage
Back to all studies
TerminatedNCT02757521

Nitrous TRD Depression in bipolarity

Medication studyAges 18–75United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

Listed locations
St LouisSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 25, 2016
Recruitment status
Terminated
Enrollment listed in the registry
1
Sponsor
Washington University School of Medicine
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT02757521
Official title
Show the full official title

Nitrous Oxide - A Novel Therapy for Treatment-Resistant Bipolar Depression

Recruitment & locations

Terminated

St Louis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Washington University School of Medicine, a university.

Does this study involve medication?

Yes. The study involves medication, including Nitrous Oxide and Placebo.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies